DiaMedica Therapeutics Inc. Common Stock
$0.00 (0.00%) As of 1:24 PM UTC pre-market
Why Robinhood?
You can buy or sell DMAC and other stocks, options, and ETFs commission-free!
About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
CEO
Rick John Pauls
Employees
11
Headquarters
Minneapolis, Minnesota
Founded
2000
DMAC Key Statistics
Market Cap
148.66M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
154.97K
High Today
$7.98
Low Today
$7.43
Open Price
$7.98
Volume
215.84K
52 Week High
$10.88
52 Week Low
$3.77
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
DMAC Earnings
-$0.23
-$0.15
-$0.08
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 10, After Hours